Skip to main content
Novartis
language-selector-globe
Choose Location
  • International
  • Americas
  • Asia Pacific
  • Europe
  • Middle East & Africa
Global | English(link is external)
Novartis Foundation | English(link is external)
Argentina | Español(link is external)
Brazil | Português(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Mexico | Español(link is external)
United States | English(link is external)
Australia | English(link is external)
Bangladesh | English(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
India | English(link is external)
Indonesia | English(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Pakistan | English(link is external)
Philippines | English(link is external)
Singapore | English(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Austria | Deutsch(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Bulgaria | Български(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hungary | Magyar(link is external)
Ireland | English(link is external)
Italy | Italiano(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Serbia | Srpski(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
Egypt | English(link is external)
Israel | עברית(link is external)
Saudi Arabia | العربية(link is external)
South Africa | English(link is external)
language-selector-globe
Choose Location
International Americas Asia Pacific Europe Middle East & Africa
Argentina | Español(link is external)
Australia | English(link is external)
Austria | Deutsch(link is external)
Bangladesh | English(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Brazil | Português(link is external)
Bulgaria | Български(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Egypt | English(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
Hungary | Magyar(link is external)
India | English(link is external)
Indonesia | English(link is external)
Ireland | English(link is external)
Israel | עברית(link is external)
Italy | Italiano(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Mexico | Español(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Global | English(link is external)
Novartis Foundation | English(link is external)
Pakistan | English(link is external)
Philippines | English(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Saudi Arabia | العربية(link is external)
Serbia | Srpski(link is external)
Singapore | English(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
South Africa | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
United States | English(link is external)
    • About 

      • Board of Directors 

        • Giovanni Caforio 
        • Simon Moroney 
        • Ton Buechner 
        • Patrice Bula 
        • Elizabeth (Liz) Doherty 
        • Ana de Pro Gonzalo 
        • Bridgette Heller 
        • Daniel Hochstrasser 
        • Frans van Houten 
        • Elizabeth McNally 
        • John D. Young 
        • Charlotte Pamer-Wieser 
      • Executive Committee 

        • Vasant (Vas) Narasimhan 
        • Shreeram Aradhye 
        • Victor Bulto 
        • Aharon (Ronny) Gal 
        • Karen L. Hale 
        • Patrick Horber 
        • Harry Kirsch 
        • Rob Kowalski 
        • Steffen Lang 
        • Fiona Marshall 
        • Lutz Hegemann 
        • Kees Roks 
        • Michelle Weese 
      • Products 
      • Therapeutic areas 

        • Cardiovascular, renal and metabolic 
        • Immunology 
        • Neuroscience 
        • Oncology 
      • People and culture 
      • Inclusion 

        • Promoting inclusion 
        • Building belonging 
        • Parental leave 
      • Novartis Gene Therapies 
      • Manufacturing 
      • Quality 

        • Audit program 
        • Novartis quality management system (QMS) 
        • Product and patient safety training 
        • Regulatory inspections 
        • Product recalls 
        • Third-party suppliers 
      • Novartis and the European Union (EU) 
      • Awards and recognition 
      Mother and daughter cuddling on a bed in a kids room

      About

      Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

    • Patients and caregivers 

      • Novartis commitment to patients and caregivers 
      • Diseases 
      • Patient organization funding 
      • Patients perspectives stories 
      Adult daughter talking to her senior parents on a bench in a park

      Patients and caregivers

      Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.

    • Healthcare professionals 

      • Medical congresses and events 

        • ASCO Annual Meeting 
      • Products 
      • Novartis pipeline 
      • Managed access programs 

        • Zolgensma® Global Managed Access Program (gMAP) 
      • Novartis external funding 
      • Healthcare professional resources by country 
      • Investigator-initiated trials / studies 
      • Novartis medical information 

        • Submit medical enquiry 
      Doctor discussing illness with patient in an office

      Healthcare professionals

      Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.

    • Research and development 

      • Technology platforms 
      • Research disease areas 

        • Cardiovascular and metabolic disease research at Novartis 
        • DAx: exploratory disease research at Novartis 
        • Global Health disease area research at Novartis 
        • Immunology disease research at Novartis 
        • Neuroscience research at Novartis 
        • Oncology research at Novartis 
      • Novartis pipeline 
      • Research collaborations 
      • Collaborations 
      A female research scientist in a lab looking at a sample

      Research & development

      Discover how Novartis turns breakthrough science into transformative, high-value treatments.
       

    • ESG 

      • Access 

        • Creating sustainable business models 
        • Value-based pricing 
        • Sub-Saharan Africa 
        • Donations 
        • Novartis access principles 
        • Novartis oncology access 
        • Patents and licensing 
      • Environmental sustainability 

        • Climate 
        • Nature - Waste 
        • Nature - Water 
      • Ethics, risk and compliance 

        • Ethical behavior 
        • Compliance 
        • Human rights 
        • Learning and engagement 
        • Integrated risk assurance 
      • Global health 

        • Pandemic preparedness 
        • Avoidable blindness 
        • Chagas disease 
        • Leprosy 
        • Malaria 
        • Sickle cell disease (SCD) 
        • Novartis Foundation  (link is external)
      • Inclusion 
      • ESG index 
      • Reporting and transparency hub 

        • ESG rating performance 
        • Targets 
        • Patient organization funding 
        • Payments to healthcare professionals 
        • Public policy 
        • A living wage 
        • A safe workplace 
        • Animal research 
      Family and friends having a party at home

      Environmental, social and governance

      Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.

    • Investors 

      • Event calendar 
      • Financial data 

        • Novartis annual results 
        • Novartis quarterly results 
        • Novartis SEC filings 
        • Product sales 
        • Fixed-income securities 
        • Expected currency impact 
      • Share data and analysis 

        • Share monitor 
        • Dividend information 
        • Share ownership 
        • Share overview 
        • Return on investment calculator 
      • Shareholder information 

        • General Meetings 
        • American Depositary Receipts (ADR) 
        • Share buyback 
        • Frequently asked questions 
      • Company overview 

        • Corporate governance 
      • Reporting and transparency hub 

        • Reporting archive 
        • ESG rating performance 
        • Publications order form 
      • ESG 
      Business woman working on her laptop in a bright atmosphere

      Investors

      Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.

    • News 

      • Newsroom 
      • Media library  
      • Stories 
      • Subscribe 
      • Events 
      Overhead view of a meeting room with people in the foreground and screens in the background

      News

      Information for journalists including media releases, statements, stories, multimedia resources and more.

    • Careers 

      • Career search 
      • Our business functions 

        • Careers in research and development 
        • Careers in operations 
        • Careers in commercial and sales 
        • Careers in global functions 
      • Why Novartis 
      • Career hub 

        • Temporary contracts  (link is external)
      • Early careers 

        • Graduates 
        • Students 
        • US Biomedical Research internship programs 
        • Community exploration and learning lab (CELL) 
      Two business people

      Careers

      Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.

    • Clinical trials 
    • Partnering 
    • Supplier portal 
    • Report side effects 
    • Contacts 
    Grandmother, mother and daughter smiling and laughing on a beach

    Home

    Working together, we can reimagine medicine to improve and extend people’s lives.

  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Sr. Spec. DDIT IES Database Services INSURGENTES Mexico Operations CTS Technology Transformation Aug 27, 2024
Buyer with German Prague Czech Republic Operations CTS Procurement Aug 23, 2024
FRA Technical Accounting & Special Projects APMA Selangor Malaysia Operations Universal Hierarchy Node Audit & Finance Aug 22, 2024
Associate Director, Business Analyst, DDIT Dev., Technical Research & Development (TRD) Barcelona Gran Vía Spain Operations Universal Hierarchy Node Technology Transformation Aug 22, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Aug 22, 2024
Associate Analyst-Master Data Management Hyderabad (Office) India Operations Innovative Medicines Technical Operations Aug 19, 2024
Analyst Stratégique H/F) en Stage Rueil-Malmaison France International Innovative Medicines Others Aug 19, 2024
Assoc. Director, Business Analyst, Technical Research & Development (TRD) Barcelona Gran Vía Spain Operations Universal Hierarchy Node Technology Transformation Aug 13, 2024
Business Analyst, DDIT Dev., Technical Research & Development (TRD) Barcelona Gran Vía Spain Operations Universal Hierarchy Node Technology Transformation Aug 13, 2024
Snr Specialist, IT Business Analyst, Technical Design (Regulatory Affairs) Barcelona Gran Vía Spain Operations Universal Hierarchy Node Technology Transformation Aug 13, 2024
Project Controller INSURGENTES Mexico Operations Innovative Medicines Technical Operations Aug 13, 2024
Senior Principal Data Scientist London (The Westworks) United Kingdom Development Innovative Medicines Data and Digital Aug 05, 2024
Assoc. Dir. DDIT Dev. GCO Tech. Design (Technical Business Analyst) Hyderabad (Office) India Operations CTS Technology Transformation Aug 05, 2024
R2R Specialist - Inventory Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Jul 28, 2024
C&Q Engineer - Senior Executive Hyderabad (Office) India Operations Innovative Medicines Technical Operations Jul 23, 2024
Junior Engineer - Conferencing (AR / VR platforms) Prague Czech Republic Operations CTS Technology Transformation Jul 22, 2024
Validation Expert İstanbul Kurtköy Türkiye Operations Innovative Medicines Technical Operations Jul 22, 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Japan Operations CTS Information Technology Jul 22, 2024
Mechanical Engineering - Executive Hyderabad (Office) India Operations Innovative Medicines Technical Operations Jul 19, 2024
Laboratory Asset Maintenance and Calibration Engineer East Hanover USA Development Innovative Medicines Technical Operations Jul 18, 2024
ERP Assurance Senior Consultant Selangor Malaysia Operations Universal Hierarchy Node Audit & Finance Jul 17, 2024
Sr.Specialist – Wireless Network Engineering INSURGENTES Mexico Operations Universal Hierarchy Node Technology Transformation Jul 16, 2024
Network Specialist INSURGENTES Mexico Operations Universal Hierarchy Node Technology Transformation Jul 16, 2024
Network Specialist INSURGENTES Mexico Operations Universal Hierarchy Node Technology Transformation Jul 16, 2024
Global Program Clinical Head East Hanover USA Development Innovative Medicines Research & Development Jul 15, 2024
Associate Manager - MS&T Hyderabad (Office) India Operations Innovative Medicines Technical Operations Jul 11, 2024
RLT Analytical Product Project Leader (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Jul 11, 2024
Specialist, Master Batch Record (MBR) Design Millburn USA Operations Universal Hierarchy Node Technology Transformation Jul 09, 2024
Specialist Resource Management Prague Czech Republic Operations CTS Technology Transformation Jul 08, 2024
Therapeutic Data Strategy Director East Hanover USA Development Innovative Medicines Research & Development Jul 02, 2024
Lead, Medical Excellence Toranomon (NPKK Head Office) Japan International Innovative Medicines Research & Development Jul 02, 2024
Automation Engineer Indianapolis USA Operations Universal Hierarchy Node Technical Operations Jun 13, 2024
(Sr.) Sales Executive-OPH Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Sales Jun 12, 2024
APPRENTI(E) ANIMATEUR SSE (H/F) Huningue France Operations Universal Hierarchy Node Others Jun 10, 2024
Principal RWE Research Analyst Hyderabad (Office) India Operations CTS Research & Development Jun 06, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Jun 05, 2024
Sourcing Manager R&D, Drug Development Hyderabad (Office) India Operations CTS Procurement Jun 04, 2024
Analyst Hyderabad (Office) India Operations CTS Marketing Jun 02, 2024
APPRENTI(E) COORDINATEUR FORMATION (H/F) Huningue France Operations Universal Hierarchy Node Others May 31, 2024
Equipment Operator Stein Aargau Switzerland Operations Innovative Medicines Technical Operations May 28, 2024
Alternant CHEF DE PROJET (Maladie de Verneuil/Urticaire Chronique) Paris Headquarter (Novartis Pharma S.A.S.) France International Universal Hierarchy Node Others May 28, 2024
Alternant INGENIEUR DATA Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 23, 2024
Senior Analyst - Data & Products Hyderabad (Office) India Operations CTS Marketing May 22, 2024
HSE Facilities Maintenances Specialist Cambridge (USA) USA Operations CTS Facilities & Administration May 22, 2024
Analyst – Patient Oriented Programs Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Senior Vendor Program Manager Hyderabad (Office) India Development Innovative Medicines Research & Development May 20, 2024
(Senior) Clinical Development Medical Director - Rheumatology East Hanover USA Development Innovative Medicines Research & Development May 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • › Next page

Novartis

Working together
  • Patients and caregivers
  • Healthcare professionals
  • Researchers
  • Job seekers
  • Journalists
  • Investors
Topics
  • Q1 2025
  • Eurovision
  • Access
  • ESG
  • SpeakUp
Explore
  • Pipeline
  • Products
  • Clinical trials
  • Partnering
  • Events
Therapeutic areas
  • Cardiovascular, renal and metabolic
  • Immunology
  • Neuroscience
  • Oncology
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
Footer Bottom
© 2025 Novartis AG
  • Terms of use
  • Privacy
  • Cookie settings
  • Contacts
  • Locations
  • Site map
  • Open source
  • Web accessibility
Novartis Site Directory
This site is intended for a global audience